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ABSTRACT 
It is well established that plasma volume decreases during spaceflight 
and simulated weightlessness (bedrest). 
thought to contribute to the orthostatic intolerance that has been 
observed in some crew members following spaceflight. To date, no studies 
have evaluated the effectiveness of fluid countermeasures of varying 
osmolality in the restoration of plasma volume and orthostatic tolerance 
in a controlled study. 
provide a model that would rapidly and safely produce a fluid loss 
comparable to that which occurs during short duration spaceflight and 2) 
design a study that would determine the optimal drink solution to restore 
orthostatic tolerance and describe the mechanism(s) whereby orthostatic 
tolerance is restored. In the first part of the study, we used a diuretic 
(Lasix) as a model for the plasma volume changes that occur during short 
duration spaceflight. Four subjects ( 3  males and 1 female) participated 
in the study. Blood samples were drawn before Lasix administration (IV) 
and every 30 minutes for 3 hours after Lasix administration. Changes in 
plasma volume and plasma osmolarity were determined for each blood sample. 
Urine flow was followed for 3 hours after Lasix injection. 
decreased by an average of 11.5 f .78% by hour 2 and then leveled of f .  
Most of the loss of plasma occurred in the first 30 minutes after Lasix 
administration (-9.5 f .45%). Plasma volume was lowest at 2 hours and 
increased slightly between 2 and 3 hours (11.5 f .85% to 10.35 f .95%). 
This might be a result of fluid shifting from other fluid compartments 
(interstitial and intracellular) into the plasma. 
decrease in plasma osmolality during the three hours following lasix 
(286.3 to 283.6 t.85 mosm), thus the fluid loss was primarily isotonic. 
Urine flows peaked at approximately 40-60 minutes after lasix (14.7 f 2.4 
ml/min) and returned to pre-lasix These data suggest 
that Lasix can be used as a model for fluid loss during short duration 
spaceflight where other models (i.e., bedrest) are not appropriate because 
of the experimental design. 
designed an experiment to examine the effectiveness of fluid 
countermeasures in the restoration of plasma volume and orthostatic 
tolerance. 
(lower body negative pressure - LBNP) will be performed in order to 
establish a baseline response. 
dehydration by Lasix administration (20 mg IV). 
dehydration experiments will be performed where LBNP will be administered 
following rehydration with a hypertonic saline solution and an isotonic 
saline solution. 
and osmolarities to compare LBNP responses. Plasma volume, leg volume, 
plasma osmolarity, forearm blood flow, heart rate, blood pressure and 
cardiac dimensions (echocardiography) will be measured during rest, LBNP 
exposure, and recovery. 
gravitational extremes (weightlessness to high G+ force). It will be 
important to document the effectiveness of countermeasures that could 
potentially minimize the negative effects of spaceflight. 
The decrement in plasma volume is 
The overall objectives of this project were to: 1) 
Plasma volume 
There was a slight 
values by 3 hours. 
In the second part of the study, we have 
For each subject, a euhydrated control orthostatic challenge 
A second condition will involve 
Two subsequent 
This will be done to produce a range of plasma volumes 
During spaceflight, man is subjected to 
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INTRODUCTION 
The cardiovascular system adapts to the weightless environment of 
space. 
The extent of the deconditioning and the mechanism of deconditioning vary 
with the individual and the duration of spaceflight. 
deconditioning are manifested upon return to the earth's atmosphere. 
Crewmembers have experienced orthostatic intolerance when they are re- 
exposed to the +1 G environment. 
reduction in systolic blood pressure and pulse pressure, and a reduction 
in exercise capacity. In order to maintain crew safety, it is necessary 
to understand the mechanisms that underlie this cardiovascular 
deconditioning and find potential countermeasures to minimize its 
negative effects. 
This is sometimes referred to as cardiovascular deconditioning. 
The effects of the 
Symptoms include tachycardia, a 
During spaceflight, there is a redistribution of fluid from the lower 
extremities t o  the head and upper body. 
blood volume expansion results in a suppressialn of antidiuretic hormone 
(ADH) and a potentiated diuresis. This has been reported to decrease 
plasma volume by 8-15% (13). Current techniques to simulate the fluid 
shifts during spaceflight are limited to bedrest and water immersion. 
Both of these are time consuming and expensive! and not appropriate for 
those studies that involve repetitive testing. 
It is thought that this central 
As a result of the plasma volume loss, the central hypervolemia that 
occurs initially is compensated for and thus e m  individual is well suited 
to a 'weightless environment. 
exposed to 1.2 to 2 +Gz, 
individuals experience cardiovascular instabil-ity. This is characterized 
by decreased blood pressure, decreased brain blood flow and in some cases 
syncope. 
manifested upon egress from the spacecraft. 
However, upon reentry crewmembers are 
and at this point due to the hypovolemia, some 
The potential for these to occur coritinues and is further 
Countermeasures are currently being developed to minimize the 
cardiovascular deconditioning that occurs during spaceflight. These 
include exercise, lower body negative pressure (LBNP) during spaceflight, 
and fluid ingestion. In short duration flight it is thought that the 
primary factor involved in deconditioning is the loss of plasma volume. 
In longer duration flights, there could be venous compliance or 
baroreceptor sensitivity changes that contribute to the cardiovascular 
deconditioning. 
Fluid countermeasures have been used for the past 15 years in both the 
Russian and US space programs. The initial coiantermeasures included water 
and saline in the form of bouillon to offset ,the natriuresis and diuresis 
that were thought to occur in response to the headward fluid shift. 
Since that time the makeup of the countermeasure has changed considerably 
including a wide variety of electrolyte suppllements. The current US 
countermeasure is salt tablets and water to make an isotonic solution 
(0.9% saline) taken 2 hours before reentry. (One recent study by Bungo 
9-3 
and Charles (2) has indicated that crewmembers who ingested a salt and 
water solution before reentry had fewer incidences of orthostatic 
intolerance upon re-exposure to gravity than those that did not use the 
countermeasure. This has yet to be validated in well controlled ground 
based research. In addition, we dont know if the mechanism for the 
restoration of orthostatic tolerance is the restoration of plasma volume. 
It is possible that there is a restoration of hydration status in other 
body fluid compartments and that this is restoring orthostatic tolerance. 
In order to evaluate the use of different drink solutions, it is first 
necessary to first develop a model for spaceflight fluid loss that can be 
used in a repeated treatment design. 
Purpose of Research 
The overall objectives of this study were: 1) develop a ground based 
simulation of changes in plasma volume during short duration spaceflight 
and 2) develop a research protocol that would determine the optimal drink 
solution to restore orthostatic responses and describe the mechanism(s) 
whereby orthostatic tolerance is restored. 
HISTORICAL BACKGROUND 
The fluid shift that occurs during spaceflight can be as much as 2 
liters. 
transiently, although this remains quite controversial (15). 
receptors are sensitive to changes in atrial pressure. Increasing stretch 
on these receptors decreases output to the anterior pituitary and thus 
decreases the output of ADH ( 6 ) .  This in turn decreases the reabsorption 
of water in the distal tubule of the kidney. In the non-human primate, 
this mechanism has been questioned (8). There was no suppression of ADH in 
response to volume expansion in the monkey. A study on Skylab failed to 
observe a diuresis. 
during spaceflight (16). 
This shift is thought to increase central venous pressure at least 
Atrial 
They report that urine flow was actually suppressed 
Recent evidence suggests that the increase in CVP is transient and might 
not be sufficient t o  stimulate a suppresion of ADH (21). 
be sufficient to stimulate an increase in the release of ANF. There are 
several resports of increased levels of AN?? in response to central volume 
expansion by head-out water immersion (4, 22). There have also has been 
reports of a decrease in fluid intake during flight, which could also 
contribute to a reduction in plasma volume. Whatever the mechanism, there 
is a decline in plasma volume during spaceflight and simulated 
weightlessness. 
between 8-15% depending on the length of the flight (13). 
weightlessness (bedrest), the blood volume loss is equivalent to what is 
observed in spaceflight however, the plasma volume losses after horizontal 
bedrest are greater (13). 
volume decrease of 15.2% following 14 days of bedrest. 
However, it might 
The decrease in plasma volume has been reported to be 
During simulated 
Greenleaf et al. (10) reported an average plasma 
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Other studies have demonstrated that dehydration either as a result of 
Luft et al. (1.8) found that leg volume 
heat stress (18), diuretic administration (19)1, or long duration exercise 
(11) decreases LBNP tolerance. 
increased and arm volume decreased progressively with LBNP, but these 
changes were significantly less after dehydration. 
Luft et al. (19) found that LBNP tolerance was reduced following oral Lasix 
administration. The Lasix produced a 16.8% reduction in plasma volume. 
Hilton et al. (11) found that after dehydration as a result of 60 minutes 
of moderate exercise, LBNP intolerance occurred even after subjects were 
rehydrated. 
In a separate study, 
To date, there have been no studies that have identified the source of 
the fluid loss. Total body water has been shown to decrease by 3% in short 
duration shuttle flights (17). It has been previously mentioned that plasma 
volume decreases by approximately 10-15% during spaceflight. 
unlikely that all of the fluid was corning solely from the plasma. There 
must be equilibration of body fluid compartments in the latter portions of 
the flight. It has yet to be determined how much fluid is coming from the 
interstitial space (ISF) and/or intracellular space (ICF) . 
It is 
As a result of cardiovascular deconditioning that occurs during 
spaceflight, there is an impairment of orthostatic responses (7,14). 
Several studies have indicated that orthostatic tolerance following bedrest 
is also impaired (10,12). 
debilitating cardiovascular deconditioning of spaceflight and its effect on 
orthostatic tolerance, three potential counteirmeasures have been developed: 
exercise, LBNP during spaceflight, and fluid ingestion before reentry. The 
effects of exercise on cardiovascular deconditioning have yet to be 
documented. However, anecdotal information co:tlected on the Skylab missions 
indicates that recovery from spaceflight was faster in those who 
participated in an inflight exercise program (20). 
used during Skylab with mixed results (14). 
bedrest study where LBNP was applied daily has demonstrated that LBNP can 
be used to offset some of the effects of weightlessness (12). 
In an attempt to reduce some of the potentially 
Inflight LBNP has been 
However, a ground based 
Several countermeasures have been used to offset the naturesis and 
diuresis that was observed during spaceflight. One of the first ingested 
countermeasures was 9-alpha-fluorohydrocortisone which minimized bed rest 
orthostatic intolerance (1). Hyatt and West ((12) used one of the first 
fluid countermeasures and found that the combined use of oral saline and 
LBNP was quite effective in returning the heart rate and blood pressure 
responses to LBNP to prebedrest values, but saline ingestion alone was less 
effective. Greenleaf et a1.(10) reported that saline consumption improves 
acceleration tolerance after bedrest by restoring plasma volume. Recently, 
Bungo et al. (2) examined the use of fluid countermeasures in several 
shuttle flights. They found that crew members that ingested a salt and 
water solution before reentry had fewer incidences of orthostatic 
intolerance upon re-exposure to gravity than those that did not use the 
countermeasure. In a recent study by Fry et d. (5), different drink 
solutions were ingested in order to determine the solution that produced 
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the greatest elevation in plasma volume and maintained the increase the 
longest. 
most effective in increasing and maintaining the higher plasma volume. It 
was superior to a number of drink solutions including an isotonic saline 
solution (the present countermeasure). 
the hypertonic solution will increase plasma volume after dehydration and 
whether it will improve orthostatic tolerance as well as the isotonic 
saline fluid countermeasure. 
They found that a slightly hypertonic saline solution (1.07%) was 
It has yet to be determined whether 
There are various techniques to assess orthostatic responses. These 
include the stand test, tilt table test, human centrifugation, and lower 
body negative pressure (LBNP). The NASA stand test has the subject lie 
supine for 5 minutes and then stand quickly. 
are then monitored for 5 minutes. This is a simple test, however, it does 
not rule out the confounding effects of muscle contraction and the 
resulting volume redistribution associated with it. By putting an 
individual on a tilt table and positioning the table to various inclines, 
the gravitational effects on the cardiovasular system can be varied. 
However, this test has limited usefulness in that it can only place a +1 Gz 
stress on the individual and it is difficult to get many physiological 
measurements during this type of testing. 
expensive and data collection is limited by the size of the centrifuge. 
Heart rate and blood pressure 
Human centrifugation is 
Lower body negative pressure allows for the gradation of the orthostatic 
stress while the subject is in the supine position. This technique 
facilitates data collection and allows for high +Gz forces to be applied to 
the subject. Lower body negative pressure results in venous pooling in the 
lower extremities. This in turn decreases cardiac filling pressure, end 
diastolic volume, and ultimately via the Frank-Starling mechanism stroke 
volume. Reflex mechanisms from both the carotid baroreceptors and 
cardiopulmonary receptors are activated which act to increase heart rate 
and total peripheral resistance to maintain arterial pressure. In 
addition, there is an increased sympathetic outflow and catecholamine 
release resulting in a reduction in end-systolic volume, thus maintaining 
stroke volume and cardiac output (24) .  
To date, no studies have evaluated the effectiveness of fluid 
countermeasures of varying osmolality in the restoration of plasma volume 
and LBNP tolerance in a controlled study. 
limited by the need to do repetitive spaceflight simulations. 
there is an effect of one bedrest on the next bedrest making it impossible 
to look at independent effects of drink solutions in subsequent bedrests. 
Diuretics will cause a dehydration as a result of increasing fluid loss in 
the urine. 
hypertension that uses furosimide as its active ingredient. 
acts to inhibit the reabsorption of sodium and chloride in the proximal and 
distal tubules, and the loop of henle. Its action is independent of any 
inhibitory effects of carbonic anhydrase or aldosterone (9). It is quick 
acting and has few side effects. For these reasons, we tried Lasix as a 
model for the fluid losses that occur during spaceflight. 
Studies of this nature have been 
For bedrest, 
Lasix is a commonly used diuretic for the treatment of 
Furosimide 
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METHODS 
Model for Plasma Volume Changes During Spaceflight 
In order to determine the total loss of plasma volume as a result of 
diuretic administration (Lasix), the time course of PV changes, the 
optimal time for fluid ingestion, and whether the loss of fluid with the 
diuretic is isotonic, four subjects were recruited and participated after 
obtaining informed consent ( 3  males and 1 female). Subjects entered the 
laboratory after a small meal in the euhydrated state. Subjects voided 
their bladder and were weighed. 
for posture before blood sampling. 
superficial arm vein. 
stasis. Twenty mg of Lasix was injected IV. 
for 3 hours after Lasix injection for urine flow determinations. 
samples were obtained every 30 minutes after Lasix. 
determined by microcentrifugation, hemoglobin was determined by a Coulter 
Counter, osmolality was determined by freezing point depression on all 
samples. From the hematocrit (HCT) and hemoglobin (HG), relative changes in 
plasma volume were determined using the formu:La of Dill and Costill (3) .  
They then sat: for 30 minutes to control 
An intracrith was inserted in a 
A preliminary blood sample ( 5  ml) was drawn without 
IJrine samples were collected 
Blood 
Hematocrit was 
Fluid Countermeasure and Orthostatic Tolerance 
Eight volunteers will be recruited for this part of the study. 
will be given several practice LBNP tests prior to the start of the 
experimental phase of the study. 
will be performed in order to establish a baseline response to LBNP. 
second condition, dehydration will be produced by a 20 mg IV injection of 
Lasix. This will produce approximately an 11X reduction in plasma volume 
from euhydrated plasma volume as has been determined from the first part of 
this project. 
subject is rehydrated after dehydration by La:six with a 14 ml/kg solution 
of a hypertonic saline solution and an isotonic saline solution. For the 
dehydration and two rehydration experiments an LBNP test will be performed. 
This will give us a range of plasma volumes and osmolarities to compare 
LBNP reponses. Each subject will complete all tests. Below is a summary of 
the 4 conditions: 
Subjects 
For each subject, control LBNP test(s) 
In a 
Two subsequent experiments will1 be performed where each 
1. Control LBNP 
2. LBNP following dehydration 
3. LBNP following dehydration and rehydration with hypertonic saline 
4. LBNP following dehydration and rehydration with isotonic saline 
The order of treatments will be randomized in order to eliminate any 
order effects on the LBNP results. All experiments will begin at the same 
time of day for each individual subject to eliminate any circadian effects 
on the findings. Testing will begin 2 hours after the ingestion of a small 
meal. LBNP will be performed 60 minutes after ingestion of fluids. 
least 72 hours will be allowed between testing. 
At 
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LBNP Protocol 
Lower body negative pressure will be applied using a plywood chamber 
sealed at the waist with a rubber gasket. 
withdraw air out of the box. 
A vacuum cleaner is then used to 
The following protocol will be used: 
Pressure (Torr) Time at Stage(min) 
Rest 
Stage 1 
Stage 2 
Stage 3 
Stage 4 
Stage 5 
Stage 6 
Stage 7 
Recovery 
0 
-5 
-10 
-20 
-30 
-40 
-50 
-60 
0 
The test will be terminated if the 
drops suddenly (greater than 25 mmHg 
10 
5 
5 
5 
5 
5 
5 
5 
10 
subject's systolic blood pressure 
in 1 minute), systolic pressure 
reaihes 80 nu&g ,-bradycardia occurs-( drop in HR greater than- 15 BPM) , 
subject distress or subject request. 
Before, during, and immediately after LBNP the parameters described below 
will be measured. 
Leg volume is calculated from leg circumference measurements made every 
minute with a mercury-in-silastic strain gauge. 
during LBNP exposure will be used to approximate the amount of venous 
pooling in the legs. 
The changes in leg volume 
A blood sample will be taken from an antecubital vein before drink 
ingestion, 30 minutes after drink ingestion, immediately before, and 
immediately after LBW (a total of seven blood samples). Changes in plasma 
volume will be calculated from hematocrit (microhematocrit technique) and 
hemoglobin (Coulter Counter) ratios using the formula of Dill and Costill 
(3) .  A direct measurement of plasma volume will be performed once (human 
serum labeled 125-1) in each subject before the first experimental testing. 
This value will be used as the absolute plasma volume and changes 
expressed relative to that value. 
using freezing point depression on all blood samples. A 5 m l  sample will be 
required to do all of the hematological analysis. 
antidiuretic hormone (ADH), atrial natriuretic factor (ANF), aldosterone, 
and catecholamines (epinephrine, norepinephrine) will be measured for each 
blood sample. These assays require a blood sample of 15 ml. 
will be 
Plasma osmolality will be determined 
Plasma levels of 
Venous occlusion plethysmography with a mercury-in-silastic strain gauge 
will be used to measure forearm blood flow. The forearm vasoconstrictor 
response as indicated by this technique will be measured at each step of 
LBNP, and plotted as a function of systolic blood pressure. 
this response will be used to estimate vasoconstrictor responses to 
The slope of 
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baroreceptor (cardiopulmonary and sinoaortic) activation induced by the 
decreasing blood pressure. Heart rate will be determined using a three 
lead EKG. The R-R interval will be determined for each stage of LBNP. The 
change in R-R interval will be plotted as a function of the systolic blood 
pressure. The slope of this relationship will be used as an estimate of 
overall baroreceptor function. 
minute using a standard auscultatory technique. 2-D and M-Mode 
echocardiography (ATL 4000 S/LC ultrasound system, ATL, Botheli, WA.) will 
be performed at each stage of LBNP in order to assess relative changes in 
left ventricular dimensions with LBNP. 
Blood pressure will be measured once a 
EMG will be used to assess abdominal and leg muscle tension in order to 
control for muscle tensing. The subject will be asked to maintain a resting 
EMG level throughout all LBNP tests. 
Urine will be collected 30 minutes after drinking and immediately after 
LBNP in order to calculate urine flow rates. 
RESULTS 
Model for Changes in Plasma Volume During Short Duration Spaceflight 
Plasma volume decreased in the first 30 minutes after Lasix 
administration (Figure 1). 
hours (11 f .78%). By 3 hours, the plasma volume was partially restored, 
most-likely as a result of fluid shifting from the ISF and'ICF compartments 
into the plasma. 
The loss of plasma volume leveled off at 2 
There were no major changes in plasma osmo1,ality for three hours after 
Lasix in comparison to pre-lasix injection (Figure 2) .  
fall in plasma osmolality (286.3 to 283.6 f .85 mosm), indicating a 
slightly hyperosmotic urine. 
There was a slight 
Urine flow for each subject is displayed in Figure 3. For all of the 
subjects, urine flow peaked between 30 and 60 minutes, then decreased back 
to control level. By 3 hours, urine flow had returned to the control value. 
In an attempt to determine the source of the fluid loss, the % loss of 
fluid from the plasma was estimated. We assumed that the plasma volume was 
45 ml/kg for men and 35 ml/kg for women. These results are displayed in 
Table 1. Overall, for the 3 male subjects, one third of the fluid loss was 
from the plasma, and thus the other two thirdls must have been from the ISF 
or ICF. The level of dehydration (-11% of the! plasma) and the time (2-3 
hours) would indicate that most of the fluid was coming from the ISF and 
not the ICF. 
DISCUSSION 
Six degree head down bedrest is currently t:he standard simulation of 
weightlessness. However, it is expensive and can not be used in repetitive 
designs. Results from the present study indicate that Lasix produces 
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comparable losses of plasma volume (11%) to that observed following 
spaceflight (10-15%) (13). 
administration. 
3 hours after oral Lasix. However, they did not follow the time course of 
the response. 
occured in the present study in the first 45 minutes following IV 
injection. 
part of this study, fluid ingestion should take place approximately 2 hours 
after lasix administration. As is the case during spaceflight the loss of 
fluid as a result of the lasix is primarily isotonic. Although, it is not 
known during spaceflight where the fluid loss is coming from, it is 
probably coming from the ISF first and then the ICF. In the present study, 
we found that approximately 1/3 of the total fluid loss was coming from the 
plasma and the rest from the other two fluid compartments (ICF and ISF). 
This is also comparable to oral Lasix 
Luft et al. (19) reported plasma volume decreased 16.8% by 
Lasix is fast acting as most of the loss of plasma volume 
By 2 hours the loss of plasma had peaked. Thus for the second 
There is the possibility that Lasix could influence the control of blood 
Lasix does alter renal 
It can increase or decrease renal blood flow depending on the 
pressure independent of the plasma volume changes. 
blood flow. 
experimental conditions (9).  
atrial natriuretic factor and renin in plasma (23). However, it is 
difficult to separate out the hypovolemic effects of furosimide and its 
direct effect on the kidney and other vascular areas. This needs to be 
taken into account when using Lasix under these conditions. Given these 
limitations, Lasix can be used to simulate the plasma volume losses that 
occur during short duration spaceflight. 
fie design presented should determine the optimal drink solution to 
Furosimide has also been shown to increase 
restore orthostatic tolerance and the mechanism whereby orthostatic 
tolerance is restored. We would anticipate, based on the study by Fry et 
a1.(5), that the optimal drink solution should be the hypertonic saline 
solution if the mechanism for restoring orthostatic tolerance is the 
restoration of plasma volume. However, it is possible that other 
mechanisms might be operational. It is possible that fluid ingested moves 
through the plasma into the ISF and ultimately the ICF,thus restoring 
hydration in cells. This could in some way restore orthostatic tolerance 
independent of restoring plasma volume. 
CONCLUSIONS 
In summary, Lasix can be used as a way of simulating the plasma volume 
The total loss of changes that occur during short duration spaceflight. 
plasma is comparable to spaceflight. Lasix is fast acting, and has 
relatively few side effects. 
The present design for evaluating the optimal fluid countermeasures will 
have important implications in restoring orthostatic tolerance and function 
in the latter stages of spaceflight when it is essential for safe operation 
of the spacecraft. 
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Figure 1. - Change in plasma volume as a function of time 
after Lasix administration. Means are plotted 2 1 SE. 
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Figure 2. - Plasma osmolality 
Lasix administration. Means are plotted 2 1 SE. 
a function of time after 
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Figure 3. - Urine flow rate as a function of time after Lasix 
administration. Individual responses are displayed. 
9-14 
Table 1.  - Total urine output and % loss of fluid from 
plasma for each subject. 
SUBJECT TOTAL URINE OUTPUT % FROM PLASMA 
(LITERS) 
1 
2 
3 -  
4 
1.58 
1.13 
1.40 
0.72 
34.5 
35.8 
31.6 
51.7 
CALCULATIONS: 
EST. PV (ML) X % LOSS OF PV 
% LOSS FROM PLASMA = 
TOTAL U R N 3  OUTPUT (L) 
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